Arcus Biosciences
RCUS
EPS for Arcus Biosciences (RCUS)
EPS in 2023 (TTM): -$3.96
According to Arcus Biosciences 's latest financial reports the company's current EPS (TTM) is -$3.96. In 2022 the company made an earnings per share (EPS) of -$3.72 a decrease over its 2021 EPS that were of $0.69.
EPS history for Arcus Biosciences from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.96 | 6.45% |
| 2022 | -$3.72 | -639.13% |
| 2021 | $0.69 | -129.36% |
| 2020 | -$2.35 | 21.13% |
| 2019 | -$1.94 | -12.61% |
| 2018 | -$2.22 | 14.77% |
| 2017 | -$1.93 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -44.95% | 🇺🇸 USA |